Healthtech Solutions, Inc./UT (HLTT) Financial Statements (2025 and earlier)
Company Profile
Business Address |
181 DANTE AVENUE TUCKAHOE, NY 10707 |
State of Incorp. | UT |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2022 | 12/31/2021 | 12/31/2020 | 6/30/2020 | |||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash, cash equivalents, and short-term investments | 7 | 129 | ||||
Cash and cash equivalents | 7 | 129 | ||||
Receivables | ||||||
Inventory, net of allowances, customer advances and progress billings | ||||||
Inventory | ||||||
Prepaid expense | 138 | 10 | ||||
Intangible current assets | ||||||
Other undisclosed current assets | 168 | |||||
Total current assets: | 313 | 139 | ||||
Noncurrent Assets | ||||||
Property, plant and equipment | ||||||
Long-term investments and receivables | 110 | |||||
Due from related parties | 110 | |||||
Intangible assets, net (including goodwill) | 26 | |||||
Intangible assets, net (excluding goodwill) | 26 | |||||
Other undisclosed noncurrent assets | ||||||
Total noncurrent assets: | 110 | 26 | ||||
TOTAL ASSETS: | 423 | 165 | ||||
LIABILITIES AND EQUITY | ||||||
Liabilities | ||||||
Current Liabilities | ||||||
Accounts payable and accrued liabilities, including: | 734 | 84 | 6 | |||
Interest and dividends payable | ✕ | 4 | ||||
Accounts payable | 80 | |||||
Other undisclosed accounts payable and accrued liabilities | 734 | 6 | ||||
Due to related parties | 13 | |||||
Other undisclosed current liabilities | 337 | 26 | ||||
Total current liabilities: | 1,071 | 84 | 45 | |||
Noncurrent Liabilities | ||||||
Long-term debt and lease obligation | 306 | |||||
Long-term debt, excluding current maturities | 306 | |||||
Liabilities, other than long-term debt | 338 | |||||
Derivative instruments and hedges, liabilities | 338 | |||||
Total noncurrent liabilities: | 644 | |||||
Total liabilities: | 1,071 | 728 | 45 | |||
Equity | ||||||
Equity, attributable to parent, including: | (648) | (563) | (45) | |||
Preferred stock | 0 | 0 | ||||
Common stock | 67 | 10 | 10 | |||
Additional paid in capital | 9,833 | 866 | ||||
Accumulated deficit | (10,548) | (1,439) | (54) | |||
Other undisclosed equity, attributable to parent | (0) | |||||
Equity, attributable to noncontrolling interest | ||||||
Total equity: | (648) | (563) | (45) | |||
TOTAL LIABILITIES AND EQUITY: | 423 | 165 |
Income Statement (P&L) ($ in thousands)
12/31/2022 | 12/31/2021 | 12/31/2020 | 6/30/2020 | ||
---|---|---|---|---|---|
Revenues | |||||
Cost of revenue | |||||
Cost of goods and services sold | |||||
Gross profit: | |||||
Operating expenses | (5,005) | (710) | (37) | ||
Other undisclosed operating income | 2,934 | 3 | |||
Operating loss: | (5,005) | (710) | (37) | ||
Nonoperating income (expense) | 3,301 | (22) | |||
Loss from continuing operations before income taxes: | (1,704) | (732) | (37) | ||
Income tax benefit | 111 | 9 | |||
Loss from continuing operations: | (1,704) | (621) | (28) | ||
Loss before gain (loss) on sale of properties: | ✕ | (2,373) | (621) | (28) | |
Loss from discontinued operations | (669) | ||||
Other undisclosed net loss | (6,736) | ||||
Net loss: | (9,109) | (621) | (28) | ||
Net income attributable to noncontrolling interest | |||||
Other undisclosed net income (loss) attributable to parent | 0 | (111) | (9) | ||
Net loss attributable to parent: | (9,109) | (732) | (37) | ||
Other undisclosed net loss available to common stockholders, basic | |||||
Net loss available to common stockholders, diluted: | (9,109) | (732) | (37) |
Comprehensive Income ($ in thousands)
12/31/2022 | 12/31/2021 | 12/31/2020 | 6/30/2020 | ||
---|---|---|---|---|---|
Net loss: | (9,109) | (621) | (28) | ||
Comprehensive loss: | (9,109) | (621) | (28) | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | |||||
Comprehensive loss, net of tax, attributable to parent: | (9,109) | (621) | (28) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.